UTAH MEDICAL PRODUCTS, INC. (UTMD) Total liabilities 2016–2025
UTAH MEDICAL PRODUCTS, INC. (UTMD) total liabilities at each fiscal year-end, per SEC filings.
$3.3MFY2025 · since FY2016: $6.9M → $3.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.3M | -35.9% |
| FY2024 | $5.1M | -28.5% |
| FY2023 | $7.1M | -25.7% |
| FY2022 | $9.6M | +13.2% |
| FY2021 | $8.5M | -4.8% |
| FY2020 | $8.9M | +2.6% |
| FY2019 | $8.7M | -19.3% |
| FY2018 | $10.8M | -26.3% |
| FY2017 | $14.6M | +110.5% |
| FY2016 | $6.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More UTMD financial trends
UTMD RevenueUTMD Net incomeUTMD Net marginUTMD Gross profitUTMD Gross marginUTMD Operating incomeUTMD Operating marginUTMD Operating cash flowUTMD Free cash flowUTMD Capital expendituresUTMD Return on equityUTMD Stock buybacksUTMD Dividends paidUTMD Total assetsUTMD Shareholders’ equityUTMD overview →